De-Risking Scientific Innovations
| Dates: | 23 April 2026 |
|---|
| Times: | 12:00 - 13:00 |
|---|
| What is it: | Webinar |
|---|
| Organiser: | Industrial Biotechnology Innovation Catalyst |
|---|
| Who is it for: | Adults |
|---|
|
Dr Johnny Habchi, Head of R&D Consulting at the Medicines Discovery Catapult, and Dr Philippa Hart, Strategy Lead at the Medicines Discovery Catapult, will lead a session on the topic below:
Early translational projects often stall not because the science is weak, but because the understanding of risk narrative, target, product, patient and pathway, is incomplete. This session will demonstrate how to convert scientific breakthroughs into partner-ready assets by framing the roadmap early, stress-testing biological plausibility and competitive context, and mapping development plans that unlock capital and partnerships.
Please register for this webinar, using this form linked here: https://forms.office.com/e/fhdmz5wQvh
Travel and Contact Information
